Vaccine manufacturing is very complex and it takes time. To think that one could announce a concept to do that and actually sign a licensing deal, do the technology transfer, bring it here, and have it up and running faster than when we expect to receive it, I don't think that would have been possible.
The time frames we're operating under are extremely tight. Before, the shortest period to develop a vaccine and commercialize was four to five years. Typically, it takes 10 to 15 years. To think that this is being done within a year is truly remarkable.
If you think about where we were a year ago, and to have vaccines being delivered, and including plans for the AstraZeneca vaccine if it is licensed, when it is licensed, to be coming forth in the second quarter is a pretty remarkable achievement. I don't think we could have done it faster with any type of licensing in or tech transfer agreements.
Licensing in, tech transfer and Canadian production all make sense to pursue, particularly in the medium term, but they would not be part of the solution for 2021.